Neurology 1611 - Neurology Alert - Nov 01, 2012

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Susan Gauthier, MS, DO
Assistant Professor of Neurology
Weill Cornell Medical College

Sotirios Keros, MD, PhD
Instructor, Department of Pediatrics
Division of Pediatric Neurology
Weill Cornell Medical College

Jai S. Perumal, MD
Assistant Professor of Neurology
Weill Cornell Medical College

Norman Latov, MD, PhD
Professor of Neurology and Neuroscience
Director of the Peripheral Neuropathy Center
Weill Cornell Medical College


  • Controlling Diabetic Neuropathic Pain
  • Should Patients with Multiple Sclerosis Avoid IVF?
  • BG-12: New Oral Medication for Relapsing-remitting MS
  • A Simple Score Can Predict Outcome after Ischemic Stroke
  • Mismatch Between Perfusion and Diffusion on MRI Can Identify Good Candidates for Endovascular Reperfusion Therapy
  • Cerebral Microbleeds May Be Associated with Elevated Vascular Endothelial Growth Factor
  • Predictors of Outcome in SCN1A-positive Dravet Syndrome
  • Antibodies to Clustered Acetylcholine Receptor in Myasthenia Gravis


  • discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • discuss the pathogenesis and treatment of pain
  • describe the basic science of brain function
  • discuss new information regarding new drugs for commonly diagnosed neurological conditions and new uses for traditional drugs
  • identify nonclinical issues of importance for the neurologist.

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editors Michael Rubin, MD, FRCP(C) and Sotirios Keros, MD, PhD, peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Assistant editor Susan Gauthier, MS, DO reports she receives research support from EMD Serono, Biogen Idec, and Novartis Pharmaceuticals, and is on the speakers bureau for Biogen Idec and Teva Neurosciences.

Author Jai S. Perumal, MD is a consultant for Biogen Idec and Genzyme, and is on the speakers bureau for Teva and Biogen Idec.

Author Norman Latov, MD, PhD has served a consultant to Grifols, Novartis, CSL Behring, Pfizer, Baxter Biotherapeutics, Elan Pharmaceuticals, and Eisai Inc. He owns stock in Therapath LLC, and is the beneficiary of a licensing agreement between Cornell University and Teva Pharmaceuticals.

Copyright 2012 AHC Media LLC. All rights reserved.